Clinical Trial Update: NMDA Enhancer for the Treatment of Mild Alzheimer's Disease [Phase 2]

View source ↗

Summary

Phase 2 trial update for a NMDA enhancer evaluated for mild Alzheimer's disease has completed enrollment and status.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Alzheimer Disease

Drugs mentioned

• NMDA enhancer (investigational)

Snippet

Sponsor: Chang Gung Memorial Hospital | Conditions: Alzheimer Disease | Phase 2 | Status: COMPLETED